194 related articles for article (PubMed ID: 23701274)
1. A randomized, double-blind, crossover, placebo-controlled trial of 6 weeks benfotiamine treatment on postprandial vascular function and variables of autonomic nerve function in Type 2 diabetes.
Stirban A; Pop A; Tschoepe D
Diabet Med; 2013 Oct; 30(10):1204-8. PubMed ID: 23701274
[TBL] [Abstract][Full Text] [Related]
2. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
[TBL] [Abstract][Full Text] [Related]
3. Variability of skin autofluorescence measurement over 6 and 12 weeks and the influence of benfotiamine treatment.
Stirban A; Pop A; Fischer A; Heckermann S; Tschoepe D
Diabetes Technol Ther; 2013 Sep; 15(9):733-7. PubMed ID: 23964994
[TBL] [Abstract][Full Text] [Related]
4. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
Flint A; Kapitza C; Hindsberger C; Zdravkovic M
Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
[TBL] [Abstract][Full Text] [Related]
5. Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetes.
Pistrosch F; Schaper F; Passauer J; Koehler C; Bornstein SR; Hanefeld M
Horm Metab Res; 2009 Feb; 41(2):104-8. PubMed ID: 19061152
[TBL] [Abstract][Full Text] [Related]
6. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
Stracke H; Gaus W; Achenbach U; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):600-5. PubMed ID: 18473286
[TBL] [Abstract][Full Text] [Related]
7. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.
Anderson RA; Evans LM; Ellis GR; Khan N; Morris K; Jackson SK; Rees A; Lewis MJ; Frenneaux MP
Diabet Med; 2006 Mar; 23(3):258-64. PubMed ID: 16492208
[TBL] [Abstract][Full Text] [Related]
8. Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes.
Forst T; Forst S; Strunk K; Löbig M; Welter K; Kazda C; Pfützner A
J Diabetes Complications; 2005; 19(3):128-32. PubMed ID: 15866056
[TBL] [Abstract][Full Text] [Related]
9. Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state.
Hohberg C; Forst T; Larbig M; Safinowski M; Diessel S; Hehenwarter S; Weber MM; Schöndorf T; Pfützner A
Diabetes Care; 2008 May; 31(5):1021-5. PubMed ID: 18268067
[TBL] [Abstract][Full Text] [Related]
10. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
[TBL] [Abstract][Full Text] [Related]
11. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
[TBL] [Abstract][Full Text] [Related]
12. Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone.
Cooper MB; Al Majali K; Bailey CJ; Betteridge DJ
Clin Endocrinol (Oxf); 2008 May; 68(5):738-46. PubMed ID: 17980009
[TBL] [Abstract][Full Text] [Related]
13. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
[TBL] [Abstract][Full Text] [Related]
14. Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).
Haupt E; Ledermann H; Köpcke W
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):71-7. PubMed ID: 15726875
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
16. Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial.
Stein P; Berg JK; Morrow L; Polidori D; Artis E; Rusch S; Vaccaro N; Devineni D
Metabolism; 2014 Oct; 63(10):1296-303. PubMed ID: 25110280
[TBL] [Abstract][Full Text] [Related]
17. Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study.
Shimabukuro M; Higa N; Chinen I; Yamakawa K; Takasu N
J Clin Endocrinol Metab; 2006 Mar; 91(3):837-42. PubMed ID: 16368744
[TBL] [Abstract][Full Text] [Related]
18. Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report.
Kim KM; Jung KY; Yun HM; Lee SY; Oh TJ; Jang HC; Lim S
Cardiovasc Diabetol; 2017 Nov; 16(1):146. PubMed ID: 29121934
[TBL] [Abstract][Full Text] [Related]
19. Dietary treatment with rice containing resistant starch improves markers of endothelial function with reduction of postprandial blood glucose and oxidative stress in patients with prediabetes or newly diagnosed type 2 diabetes.
Kwak JH; Paik JK; Kim HI; Kim OY; Shin DY; Kim HJ; Lee JH; Lee JH
Atherosclerosis; 2012 Oct; 224(2):457-64. PubMed ID: 22954674
[TBL] [Abstract][Full Text] [Related]
20. Effects of rosiglitazone on postprandial leukocytes and cytokines in type 2 diabetes.
van Wijk JP; Cabezas MC; Coll B; Joven J; Rabelink TJ; de Koning EJ
Atherosclerosis; 2006 May; 186(1):152-9. PubMed ID: 16137694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
